TiumBio Statistics

Total Valuation

TiumBio has a market cap or net worth of KRW 143.85 billion. The enterprise value is 139.42 billion.

Market Cap	143.85B
Enterprise Value	139.42B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

TiumBio has 26.99 million shares outstanding. The number of shares has increased by 6.16% in one year.

Current Share Class	26.99M
Shares Outstanding	26.99M
Shares Change (YoY)	+6.16%
Shares Change (QoQ)	+2.38%
Owned by Insiders (%)	35.22%
Owned by Institutions (%)	0.32%
Float	15.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	20.83
PB Ratio	2.63
P/TBV Ratio	3.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.60
EV / Sales	20.19
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.90

Financial Position

The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.67.

Current Ratio	2.25
Quick Ratio	1.97
Debt / Equity	0.67
Debt / EBITDA	n/a
Debt / FCF	-2.34
Interest Coverage	-4.72

Financial Efficiency

Return on equity (ROE) is -40.75% and return on invested capital (ROIC) is -12.49%.

Return on Equity (ROE)	-40.75%
Return on Assets (ROA)	-11.07%
Return on Invested Capital (ROIC)	-12.49%
Return on Capital Employed (ROCE)	-23.75%
Revenue Per Employee	101.57M
Profits Per Employee	-310.52M
Employee Count	68
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.24% in the last 52 weeks. The beta is 0.62, so TiumBio's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	-17.24%
50-Day Moving Average	5,178.70
200-Day Moving Average	4,806.88
Relative Strength Index (RSI)	45.48
Average Volume (20 Days)	205,998

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TiumBio had revenue of KRW 6.91 billion and -21.12 billion in losses. Loss per share was -806.19.

Revenue	6.91B
Gross Profit	6.67B
Operating Income	-19.43B
Pretax Income	-24.17B
Net Income	-21.12B
EBITDA	-15.69B
EBIT	-19.43B
Loss Per Share	-806.19

Full Income Statement

Balance Sheet

The company has 52.46 billion in cash and 36.70 billion in debt, giving a net cash position of 15.76 billion or 583.98 per share.

Cash & Cash Equivalents	52.46B
Total Debt	36.70B
Net Cash	15.76B
Net Cash Per Share	583.98
Equity (Book Value)	54.65B
Book Value Per Share	1,621.61
Working Capital	34.25B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -14.65 billion and capital expenditures -1.01 billion, giving a free cash flow of -15.66 billion.

Operating Cash Flow	-14.65B
Capital Expenditures	-1.01B
Free Cash Flow	-15.66B
FCF Per Share	-580.16

Full Cash Flow Statement

Margins

Gross Margin	96.54%
Operating Margin	-281.30%
Pretax Margin	-349.92%
Profit Margin	n/a
EBITDA Margin	-227.18%
EBIT Margin	-281.30%
FCF Margin	n/a

Dividends & Yields

TiumBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.16%
Shareholder Yield	n/a
Earnings Yield	-14.68%
FCF Yield	-10.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TiumBio has an Altman Z-Score of 1.1 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.1
Piotroski F-Score	3